SYK expression level distinguishes control from BRCA1-mutated lymphocytes
Tamar Zahavi,1,2,* Amir Sonnenblick,1,3,* Yael Shimshon,2 Luna Kadouri,1 Tamar Peretz,1 Asher Y Salmon,1,* Mali Salmon-Divon,2,* 1Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel; 2Genomic Bioinformatics Laboratory, Department of Molecular Biology, Ariel Un...
Main Authors: | Zahavi T, Sonnenblick A, Shimshon Y, Kadouri L, Peretz T, Salmon AY, Salmon-Divon M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-03-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/syk-expression-level-distinguishes-control-from-brca1-mutated--lymphoc-peer-reviewed-article-CMAR |
Similar Items
-
The Acidic Stress Response of the Intracellular Pathogen <i>Brucella melitensis</i>: New Insights from a Comparative, Genome-Wide Transcriptome Analysis
by: David Kornspan, et al.
Published: (2020-08-01) -
Use of Gene Expression Profiles of Peripheral Blood Lymphocytes to Distinguish BRCA1 Mutation Carriers in High Risk Breast Cancer Families
by: Marie-Laure Vuillaume, et al.
Published: (2009-01-01) -
Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment
by: Ari Raphael, et al.
Published: (2022-09-01) -
Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
by: Liat Anabel Sinberger, et al.
Published: (2023-11-01) -
Transcriptomic analysis of smooth versus rough Brucella melitensis Rev.1 vaccine strains reveals insights into virulence attenuation
by: Mali Salmon-Divon, et al.
Published: (2020-01-01)